麻豆传媒

Many also had adrenal abnormalities

Adolescence is a critical period in T1D, associated with hyperfiltration and high HbA1c levels

Randomized trial failed to get anywhere near tight glucose control

Phase II data support testing pemvidutide for comorbid obesity and liver conditions

Insulin sensitivity also improved in people with obesity free of diabetes

SECURE-T2D trial provides pivotal findings to expand use of the Omnipod 5 System

INHALE 3 provides insights into dosing and who might actually do worse than with a pump

Randomized trial shows a benefit of an inexpensive cholesterol drug

Zepbound met primary and secondary endpoints, with or without CPAP

FDA Commissioner Robert Califf, MD, talks tech

Advance of disease driven by high BMI, with social determinants of health playing a role

Endocrinologists urged to pay attention to COORDINATE trial

But GI side effects higher than other comparable anti-obesity agents

Once-weekly CagriSema reduced body weight more than either agent alone